bioMérieux company profile

BIM · Euronext Paris · EUR

Compare bioMérieux
€91.30Change from previous close: +0.16%Absolute change: +€0.15

Close · November 20, 2026

Company profile

bioMérieux has 14,562 employees and is headquartered in Marcy-l'Étoile, France.

Many clinicians and laboratories know bioMérieux through VITEK 2, BIOFIRE and VIDAS, the systems used to identify bacteria, test their resistance to antibiotics and detect infections. The range also includes BACT/ALERT blood culture instruments, the VITEK MS mass spectrometry platform and API identification strips. Beyond these instruments, the group supplies culture media, PCR tests for viral respiratory infections and detection kits for the food industry, along with lab consultancy and training. It sells in France, across Europe, Africa, the Middle East, the Americas and Asia Pacific.

In the fiscal year ended December 2025, bioMérieux reported revenue of 4.1 billion euros, up 2.3% from the previous year, and net income of 397.5 million euros. The company is headquartered in Marcy-l'Étoile, France, was founded in 1963 and employs 14,562 people.

Company facts

Industry
Diagnostics & Research
Country
France
Headquarters
376 Chemin De l’Orme, 69280, Marcy-l'Étoile
Employees
14,562
Chief executive
Pierre Boulud
Founded
1963
Fiscal year
January - December
Listing
BIM · Euronext Paris
Currency
EUR
ISIN
FR0013280286

bioMérieux and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
bioMérieuxBIMFrance$11.82B14,56216.0%23.4
QiagenQIAGermany$10.23B5,40026.7%28.5
Eurofins ScientificERFFrance$16.03B65,00014.1%29.6
DiaSorinDIAItaly$4.21B3,21222.3%28.6
Lonza GroupLONNSwitzerland$54.2B20,14123.5%43.2
DiagnostykaDIAPoland$1.27B8,64514.9%20.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare bioMérieux with its competitors